Vanguard Group Inc Merck & Co., Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 243,269,899 shares of MRK stock, worth $31.9 Billion. This represents 0.65% of its overall portfolio holdings.
Number of Shares
243,269,899
Previous 244,776,747
0.62%
Holding current value
$31.9 Billion
Previous $26.7 Billion
20.29%
% of portfolio
0.65%
Previous 0.59%
Shares
13 transactions
Others Institutions Holding MRK
# of Institutions
3,757Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Black Rock Inc. New York, NY207MShares$27.2 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$15.4 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$11.3 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.4 Billion0.7% of portfolio
-
Morgan Stanley New York, NY41.5MShares$5.45 Billion0.45% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $332B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...